Metformin-associated lactic acidosis in a pregnant patient
discuss this article
Gynecol Obstet Invest 2008;66:138-141 (DOI:10.1159/000132463) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Non-random distribution and sensory functions of primary cilia in vascular smooth muscle cells
discuss this article
Kidney Blood Press Res 2008;31:171-184 (DOI:10.1159/000132462) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients
discuss this article
Nephron Clin Pract 2008;109:c9 (DOI:10.1159/000132391) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
The genetics of carotid dissection: meta-analysis of a mthfr/c677t common molecular variant
discuss this article
Cerebrovasc Dis 2008;25:561-565 (DOI:10.1159/000132202) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis
discuss this article
ORL 2008;70:257-263 (DOI:10.1159/000133280) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Analysis of life-threatening complications of deep neck abscess and the impact of empiric antibiotics
discuss this article
ORL 2008;70:249-256 (DOI:10.1159/000132094) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Efficacy of unilateral stenting in idiopathic intracranial hypertension with bilateral venous sinus stenosis
discuss this article
Eur Neurol 2008;60:47-48 (DOI:10.1159/000131712) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Subacute combined degeneration of the cord: putnam-dana syndrome
discuss this article
Eur Neurol 2008;60:53-56 (DOI:10.1159/000131715) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
The doctrine of signatures
discuss this article
Eur Neurol 2008;60:51-52 (DOI:10.1159/000131714) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Spigc news
discuss this article
Eur Surg Res 2008;40:368 (DOI:10.1159/000134084) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Neuroimage: giant intracranial lipoma with extracranial extension
discuss this article
Eur Neurol 2008;60:49-50 (DOI:10.1159/000131713) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Assessment of vocal capacity of finnish university students
discuss this article
Folia Phoniatr Logop 2008;60:199-209 (DOI:10.1159/000133651) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Long-term outcome after combined radiochemotherapy for anal cancer -- retrospective analysis of efficacy, prognostic factors, and toxicity
discuss this article
Onkologie 2008;31:251-257 (DOI:10.1159/000121362) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Gefitinib in combination with oxaliplatin and 5-fluorouracil in irinotecan-refractory patients with colorectal cancer: a phase i study of the arbeits gemeinschaft internistische onkologie (aio)
discuss this article
Onkologie 2008;31:237-241 (DOI:10.1159/000122029) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Long-term survival in stage iv melanoma after repetitive surgical therapy
discuss this article
Onkologie 2008;31:259-261 (DOI:10.1159/000121409) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Perforation of the superior vena cava -- a rare complication of central venous catheters
discuss this article
Onkologie 2008;31:262-264 (DOI:10.1159/000122071) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Mitomycin c in the treatment of gastrointestinal tumours: recent data and perspectives
discuss this article
Onkologie 2008;31:271-281 (DOI:10.1159/000122590) (Source: Karger Publishers)
Source: Karger Publishers - May 17, 2008 Category: Cancer & Oncology Source Type: journals
Review finds in favor of mri screening for breast cancer
discuss this article
There is some evidence that screening programs for women at very high risk for breast cancer would be improved by complementing mammography with magnetic resonance imaging, say the authors of a review. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - May 17, 2008 Category: Cancer & Oncology Source Type: news
Risk for urologic cancer linked to risk for colorectal cancer
discuss this article
Patients with renal pelvis and ureteral cancers have an increased risk for colorectal cancer, and in turn, a history of colorectal cancer increases the risk for renal pelvis and ureteral cancers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2008 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: info
Ning wong of fox chase cancer center receives asco cancer foundation career development award
discuss this article
The American Society of Clinical Oncology Cancer Foundation has selected Yu-Ning Wong, M.D., M.S.C.E., of Fox Chase Cancer Center, as one of 13 clinicians to receive a 2008 Career Development Award. Career Development Awards are presented to physicians in their second, third or fourth year as full-time faculty members in an academic setting. This award marks the third time ASCO has honored Wong's accomplishments since she began her professional career in oncology in 2002. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
Bone drug could help prevent the spread of breast cancer
discuss this article
Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to research at Washington University School of Medicine in St. Louis.Bones are common sites for the spread, or metastasis, of breast cancer. Scientists here found that women treated for stage II/III breast cancer who also received a bone strengthening drug were less likely to have breast tumor cells growing in their bones after three months. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
New treatment implications for ovarian cancer unveiled
discuss this article
New research findings from a top clinical investigator at The Cancer Institute of New Jersey (CINJ) indicate the potential for more targeted treatment of ovarian cancer, which is expected to claim more than 15,000 lives nationwide this year, with 480 in New Jersey. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
Memory pharmaceuticals highlights progress with key programs at its r&d day
discuss this article
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced progress with several key development programs at its R&D Day meeting with the investment community. The Company reported new clinical data for MEM 1414, its lead PDE4 inhibitor, demonstrating the compound's CNS activity in humans. In addition, the Company has nominated MEM 68626 as the lead development candidate from its 5-HT6 antagonist program, and separately confirmed its 2008 development goals for its pipeline. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
Rosetta genomics to present multiple posters at the 44th annual meeting of the american society of clinical oncology (asco)
discuss this article
Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced that it will present multiple posters at the upcoming ASCO annual meeting in Chicago. The company also has three publication only abstracts available on ASCO's website. The event will take place from May 30 to June 3 at the McCormick Place, Chicago, Illinois. Presented posters: 1. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
Significant anti-tumor activity of nktr-102 in patients with refractory solid tumors; interim data published in asco 2008 proceedings
discuss this article
Nektar Therapeutics (Nasdaq: NKTR) announced initial results from a Phase 1 study of NKTR- 102, PEGylated irinotecan. The data shows significant anti-tumor activity in patients with refractory solid tumors. The study also demonstrates that Nektar's small molecule PEGylation technology produced an increase in SN38 exposure that was up to six-fold higher than the exposure previously reported with irinotecan at equivalent doses. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - May 17, 2008 Category: Cancer & Oncology Source Type: news
Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma
discuss this article
The combination of gemcitabine and docetaxel has demonstrated promise in sarcomas diagnosed in adults. In the current study, the toxicity and efficacy of this combination were evaluated in pediatric sarcomas.A retrospective case review of 22 patients with recurrent or refractory bone or soft-tissue sarcomas who received gemcitabine (at a dose of 675 mg/m2 intravenously on Days 1 and 8) and docetaxel (at a dose of 75-100 mg/m2 intravenously on Day 8) was undertaken.The patients (ages 8-23 years) received a total of 109 courses of chemotherapy (median, 4 courses; range, 1-13 courses). Seventeen patients had osteosarcoma, 2 p...
Source: Cancer - May 17, 2008 Category: Cancer & Oncology Authors: Fariba Navid, Jennifer Reikes Willert, M. Beth McCarville, Wayne Furman, Amy Watkins, William Roberts, Najat C. Daw Source Type: journals
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia - a comparative study of four differently designed, high resolution microarray platforms
discuss this article
Screening for gene copy-number alterations (CNAs) has improved by applying genome-wide microarrays, where SNP arrays also allow analysis of loss of heterozygozity (LOH). We here analyzed 10 chronic lymphocytic leukemia (CLL) samples using four different high-resolution platforms: BAC arrays (32K), oligonucleotide arrays (185K, Agilent), and two SNP arrays (250K, Affymetrix and 317K, Illumina). Cross-platform comparison revealed 29 concordantly detected CNAs, including known recurrent alterations, which confirmed that all platforms are powerful tools when screening for large aberrations. However, detection of 32 additional ...
Source: Genes, Chromosomes and Cancer - May 17, 2008 Category: Cancer & Oncology Authors: Rebeqa Gunnarsson, Johan Staaf, Mattias Jansson, Anne Marie Ottesen, Hanna Göransson, Ulrika Liljedahl, Ulrik Ralfkiær, Mahmoud Mansouri, Anne Mette Buhl, Karin Ekström Smedby, Henrik Hjalgrim, Ann-Christine Syvänen, Åke Borg, Anders Isaksson, Jesper Source Type: journals
Breast cancer screening: evidence for false reassurance?
discuss this article
Tumour stage distribution at repeated mammography screening is, unexpectedly, often not more favourable than stage distribution at first screenings. False reassurance, i.e., delayed symptom presentation due to having participated in earlier screening rounds, might be associated with this, and unfavourably affect prognosis. To assess the role of false reassurance in mammography screening, a consecutive group of 155 breast cancer patients visiting a breast clinic in Rotterdam (The Netherlands) completed a questionnaire on screening history and self-observed breast abnormalities. The length of time between the initial discove...
Source: International Journal of Cancer - May 17, 2008 Category: Cancer & Oncology Authors: Rianne de Gelder, Elisabeth van As, Madeleine M.A. Tilanus-Linthorst, Carina C.M. Bartels, Rob Boer, Gerrit Draisma, Harry J. de Koning Source Type: journals
Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study
discuss this article
Conclusion: The CARS-DLV proved to be a valuable instrument to measure women's' concerns about breast cancer recurrence. More than half of former breast cancer patients indicated moderate to severe concerns about disease recurrence. Health and death worries were the most prominent. The levels of worry were independent of the time since diagnosis. Copyright © 2008 John Wiley & Sons, Ltd. (Source: Psycho-Oncology)
Source: Psycho-Oncology - May 17, 2008 Category: Cancer & Oncology Authors: Marieke H. J. van den Beuken-van Everdingen, Madelon L. Peters, Janneke M. de Rijke, Harry C. Schouten, Maarten van Kleef, Jacob Patijn Source Type: journals
Act now to increase funding for nih and nsf!!
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
discuss this article
M. D. Anderson News Release 05/15/08
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center. This finding demonstrates the significance of COX-2 inhibition toward preventing lung cancer in individuals at higher risk of developing the disease. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Drug therapy to bolster immune system cells found effective toward childhood cancer
discuss this article
Combination could help children fight cancer without additional harsh therapiesM. D. Anderson News Release 05/15/08
Researchers from The University of Texas M. D. Anderson Cancer Center have found a possible approach to therapy that may make cancer cells more sensitive to attack by immune system cells while making the immune system cells more powerful. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
M. d. anderson nurses find empowerment in pacts
discuss this article
Ad hoc, Multidisciplinary Teams See Major Growth in ParticipationM. D. Anderson News Release 05/15/08
According to nurse-researchers at The University of Texas M. D. Anderson Cancer Center in Houston, participation among nurses in the institution's unique Professional Action Coordinating Teams (PACTs) has increased 50 percent in one year. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Study takes a step toward better defining fatigue
discuss this article
M. D. Anderson Study Identifies Common Threads Among Cancer Patients Receiving Radiation TherapyM. D. Anderson News Release 05/15/08
In an effort to better define and ultimately address fatigue more effectively, a qualitative study from The University of Texas M. D. Anderson Cancer Center has identified three primary themes - loss of strength or energy, major effects of fatigue and associated sensations - among patients being treated with standard radiation therapy. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Dan l. duncan family foundation gives m. d. anderson its largest gift aimed solely at preventing cancer
discuss this article
$35 Million Donation Establishes the Dan Duncan Family Institute for Cancer Prevention and Risk Assessment at M. D. AndersonM. D. Anderson News Release 05/15/08
The Dan L. Duncan Family Foundation has given The University of Texas M. D. Anderson Cancer Center $35 million-the institution's largest gift to the cancer prevention program and its second-largest gift in its 67-year history. The funds will be used to establish the Dan Duncan Family Institute for Cancer Prevention and Risk Assessment. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
New drug combination brings one-two punch against acute leukemia
discuss this article
M. D. Anderson News Release 05/16/08
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Researchers expand natural killer cells in cord blood to fight leukemia
discuss this article
M. D. Anderson News Release 05/16/08
Researchers from The University of Texas M. D. Anderson Cancer Center have found a therapy that effectively kills human leukemia cells in mice using natural killer (NK) cells from umbilical cord blood. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
discuss this article
First positive findings in breast cancer for this class of drugsM. D. Anderson News Release 05/15/08
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 16, 2008 Category: Cancer & Oncology Authors: M. D. Anderson Cancer Center Source Type: organizations
Prostate cancer risk gene combinations vary between ethnic groups
discuss this article
Scientists have identified variant gene combinations that increase the likelihood for prostate cancer, and found that the risk associated with the different combinations varies between Hispanic White and non-Hispanic White men. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - May 16, 2008 Category: Cancer & Oncology Source Type: news
Prostate cancer risk gene combinations vary between ethnic groups
discuss this article
Scientists have identified variant gene combinations that increase the likelihood for prostate cancer, and found that the risk associated with the different combinations varies between Hispanic White and non-Hispanic White men. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 16, 2008 Category: Cancer & Oncology Source Type: news
Nccn non-small cell lung cancer guidelines update
discuss this article
Review how new NCCN updates will impact the management of non-small cell lung cancer. (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 16, 2008 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: info
Can opiates be administered by nebulizer?
discuss this article
Some clinicians are using nebulized morphine to treat pain and breathlessness in patients with COPD and CHF, but is there evidence to back that up?
Medscape Pharmacists (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 16, 2008 Category: Cancer & Oncology Tags: Pharmacist Source Type: info
Studies examine ultrasounds for breast cancer detection, teen exercise on cancer risk
discuss this article
Using ultrasounds in addition to mammograms is more effective at detecting breast cancer than only using mammograms, according to a study published Wednesday in the Journal of the American Medical Association, USA Today reports. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - May 16, 2008 Category: Cancer & Oncology Source Type: news
Avastin improves brain cancer survival
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Monmouth medical center brain tumor center hosts celebration of survival
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Dach1 used to block metastasis in breast cancer cells
discuss this article
US researchers have used the cell-fate determination factor DACH1 to block oncogene-dependent tumor metastasis in breast epithelial cells. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - May 16, 2008 Category: Cancer & Oncology Source Type: news
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Regional hypoxia in glioblastoma multiforme quantified with [18f]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
Safety of anticoagulation use and bevacizumab in patients with glioma
discuss this article
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2008 Category: Cancer & Oncology Source Type: info
